The 36-month beta value for NUTX is also noteworthy at 0.70. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The average price estimated by analysts for NUTX is $2.38, which is $2.16 above than the current price. The public float for NUTX is 334.68M, and at present, short sellers hold a 0.34% of that float. The average trading volume of NUTX on September 18, 2023 was 2.53M shares.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
NUTX) stock’s latest price update
The stock price of Nutex Health Inc. (NASDAQ: NUTX) has jumped by 6.12 compared to previous close of 0.21. Despite this, the company has seen a fall of -15.87% in its stock price over the last five trading days. PRNewsWire reported 2023-09-07 that HOUSTON, Sept. 7, 2023 /PRNewswire/ — Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announced that Thomas Vo, M.D.
NUTX’s Market Performance
NUTX’s stock has fallen by -15.87% in the past week, with a monthly drop of -32.21% and a quarterly drop of -45.23%. The volatility ratio for the week is 10.82% while the volatility levels for the last 30 days are 10.62% for Nutex Health Inc. The simple moving average for the last 20 days is -19.29% for NUTX’s stock, with a simple moving average of -75.58% for the last 200 days.
Analysts’ Opinion of NUTX
Many brokerage firms have already submitted their reports for NUTX stocks, with Northland Capital repeating the rating for NUTX by listing it as a “Outperform.” The predicted price for NUTX in the upcoming period, according to Northland Capital is $3 based on the research report published on February 22, 2023 of the current year 2023.
NUTX Trading at -34.80% from the 50-Day Moving Average
After a stumble in the market that brought NUTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -90.94% of loss for the given period.
Volatility was left at 10.62%, however, over the last 30 days, the volatility rate increased by 10.82%, as shares sank -25.46% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -42.64% lower at present.
During the last 5 trading sessions, NUTX fell by -15.87%, which changed the moving average for the period of 200-days by -85.57% in comparison to the 20-day moving average, which settled at $0.2733. In addition, Nutex Health Inc. saw -88.23% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at NUTX starting from Vo Thomas T., who purchase 152,326 shares at the price of $0.28 back on Aug 31. After this action, Vo Thomas T. now owns 269,322,776 shares of Nutex Health Inc., valued at $42,651 using the latest closing price.
Vo Thomas T., the Chief Executive Officer of Nutex Health Inc., purchase 305,947 shares at $0.31 during a trade that took place back on Aug 30, which means that Vo Thomas T. is holding 269,170,450 shares at $94,844 based on the most recent closing price.
Stock Fundamentals for NUTX
Current profitability levels for the company are sitting at:
- -2.09 for the present operating margin
- +6.13 for the gross margin
The net margin for Nutex Health Inc. stands at -193.70. The total capital return value is set at -1.96, while invested capital returns managed to touch -203.58. Equity return is now at value -444.90, with -100.60 for asset returns.
Based on Nutex Health Inc. (NUTX), the company’s capital structure generated 278.73 points at debt to equity in total, while total debt to capital is 73.60. Total debt to assets is 61.89, with long-term debt to equity ratio resting at 256.73. Finally, the long-term debt to capital ratio is 67.79.
When we switch over and look at the enterprise to sales, we see a ratio of 1.93, with the company’s debt to enterprise value settled at 0.18. The receivables turnover for the company is 7.26 and the total asset turnover is 0.85. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.79.
Conclusion
In summary, Nutex Health Inc. (NUTX) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
